Cannabinoid patents



Although the cannabinoids THC and CBD are the only two cannabinoids required to be disclosed by the Licensed Producers under Canada's marijuana legislation, some dispensaries in the US also only disclose these two cannabinoids in their strains, choosing to ignore the following cannabinoids that have a greater presence over CBD in Indica strains: 


Cannabigerol (CBG) - the link for this cannabinoid is for a patent application filed by GW Pharmaceuticals in treating depression and other mood disorders. 

CBG for a number of diseases - the diseases or conditions to be treated are taken from the group: pain, neurodegenerative disease, ischemic disease, brain injury or damage, acquired brain injury, age related inflammatory or autoimmune disease, cachexia, nausea and vomiting, glaucoma, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia and nephritis.  This was filed by GW Pharma

Cannabichromene (CBC) - GW Pharma claims to have invented a method for extracting this cannabinoid

CBC and Terpenes  - GW's invention in this patent is in the treatment of cancer  where the use of at least 50% of the phytocannabinoid component is not THC or CBD but CBC and with at least 15% of the non-phytocannabinoid containing component comprising certain terpenes such as myrcene and pinene. 

CBC as an antiinflammatory and antimicrobial  - filed by the University of Mississippi

Tetrahydrocannabivarin (THCV) -  by GW Pharma - using THCV for the treatment of obesity, schizophrenia, epilepsy, Alzheimer's, bone disorders, bulimia or the treatment of drug, alcohol or nicotine abuse or dependency

THCV, CBG, CBC and/or CBDV for intestinal inflammatory diseases -  this patent application filed by GW Pharma is for any one of the named cannabinoids for the preferential treatment of either ulcerative colitis or Crohn's disease


The above patents are just a drop in the bucket relative to the number of studies conducted and patent applications filed using cannabis's medicinal properties.






No comments: